Clinical Trials on Craniotomy Tumor Removal Surgery in Hong Kong
Total 0 results
Nothing found
Sponsors and Collaborators
- Paulo Sérgio Gomes Nogueira Borges
- Korea Otsuka International Asia Arab
- Arsha Vidya Tirtha
- University of Applied Sciences Jena
- Klinik für Allgemein- und Viszeralchirurgie, Department Chirurgie, Luzerner Kantonsspital
- United States Department of Defense (DOD)
- S-Biotek Holding ApS
- Cardiovascular Center Dedinje, Belgrade, Serbia
- Gunkang Pharmaceuticals, Inc
- Sudimplant SAS - Groupe TBR
- Eurotrials Brasil Consultores Cientificos Ltda
- Julian Taylor Green
- 904 Hospital of the People's Liberation Army Joint Logistic Support Force
- Rivierduinen, Centre for Personality disorders Jelgersma
- Foshan Sanshui District People's Hospital
- Plethora Solutions Ltd
- Iyad Naeem Muhammad, PhD
- Lilly PharmaceuticalCompany
- Oblikue Consulting
- Foundation for Biosanitary Research and Innovation in Primary Health Care
- View Full List
Medical Conditions
- Vibration; Exposure
- Malaria,Falciparum
- Huntington Chorea
- Relapsed or Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Lymphoma)
- Anemia Acute
- Deformity Flexion
- Immunologically-induced Lung Disease
- Post-discharge Pharmacist Counseling to Prevent Readmissions
- Blepharospasm of Both Eyelids
- Chemotherapy-Induced Neutropenia
- Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8
- Gray Platelet Syndrome
- Hypothermia Following Anesthesia, Sequela
- Thyroid and Parathyroid Surgery
- Puberty, Delayed
- Visual Attention Span Deficit
- Brain Tumor, Primary
- Serum Albumin Low
- Advance Directive Completion
- Testicular Teratoma
- View Full List
Drug Interventions
- Ebselen
- Pemetrexed
- F520
- Standard medical therapy
- Vosaroxin
- Acalabrutinib in combination with VR
- Cyanoacrylate
- Oxycodone
- Mineralocorticoid receptor antagonist
- Celecoxib
- Bimatoprost 0.03% eye drops
- Sorafenib
- Cytisine
- Rovalpituzumab tesirine
- ABY-035 i.v.
- MMV390048 120mg
- S-Adenosyl-Methionine
- Recombinant monoclonal antibody against human epidermal growth factor receptor injection (HS627)
- Furmonertinib 160 mg
- Pegfilgrastim
- View Full List
CROs by country
- Contract Research Organizations in Algeria
- Contract Research Organizations in Australia
- Contract Research Organizations in Bangladesh
- Contract Research Organizations in Cote d'Ivoire
- Contract Research Organizations in Ghana
- Contract Research Organizations in Hong Kong
- Contract Research Organizations in Mexico
- Contract Research Organizations in Mozambique
- Contract Research Organizations in Saudi Arabia
- Contract Research Organizations in Senegal
- Contract Research Organizations in Slovakia
- Contract Research Organizations in Tunisia
- Contract Research Organizations in United Arab Emirates
- CRO list by country